
News
Novartis invests 63 million euros in its Barcelona plant and converts it into a European antibiotics production centre
The Swiss group Novartis, one of the world leaders in biomedical innovation in cardiology, oncology, immunology, neuroscience, ophthalmology and respiratory areas, will invest 77.4 million euros to expand its production activity in Spain.
Subscribe to our Newsletter
Subscribe
Follow us on social